/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Symptom of dyspnea among all-comers admitted for acute myocardial infarction is an independent and powerful predictor of poor in-hospital outcomes
Event: Heart Failure 2023
Topic: Clinical
Session: Coronary artery disease / Chronic coronary syndromes
Left atrial strain is improved with addition vs. no addition of SGLT2 inhibitor to background heart failure pharmacotherapy among patients with HFrEF: a prospective cohort study with 3-month follow-up
Event: Heart Failure 2023
Topic: Imaging
Session: Chronic heart failure - imaging 2
The association of CABG vs. PCI on echocardiographic indices of global longitudinal strain and myocardial work in patients with HFrEF and ischemic cardiomyopathy: a pilot study
Event: Heart Failure 2022
Topic: Imaging
Session: Heart Failure ePosters - focus on Chronic Heart Failure 4
Patients with non-ischemic dilated cardiomyopathy and AF exhibit worse global longitudinal strain and reduced work index and constructive work of the myocardium compared to those without AF
Event: Heart Failure 2022
Topic: Heart Failure in Atrial Fibrillation
Session: Heart Failure ePosters - focus on Arrhythmias and device
Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials
Event: ESC Congress 2021 - The Digital Experience
Topic: Antiarrhythmic Pharmacotherapy
Session: Pharmacology and pharmacotherapy e-posters
The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on ischemic outcomes among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 106,405 patients from 12 studies
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on major bleeding among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 41,548 patients from 11 studies
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
Event: Heart Failure 2021
Topic: Angiotensin-Renin-Bradykinin System
Session: ePoster session
Use of SGLT2 inhibitors and the incidence of urinary tract infections in patients with heart failure: a pooled analysis of four trials including 26,838 patients
Event: Heart Failure 2021
Topic: Antidiabetic Pharmacotherapy
Session: ePoster session
The predictive value of CHA2DS2-VASc score on adverse in-hospital outcomes among patients with the acute coronary syndrome and atrial fibrillation who undergo PCI
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Epidemiology, Prognosis, Outcome in Acute Coronary Syndromes – New Insights
ESC 365 is supported by
